DONIKA K PATEL
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology GREENSBORO, NC NPI 1508006776
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NC ABBVIE INC. All categories
General Payments — all program years on this page
$6,759.03
- Category: General Payments
- Program years: PY2018–2024
- Record count: 398
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,300.34 across 64 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,198.02 | 62 |
| Education | $102.32 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $211.51 | 19 |
| Alexion Pharmaceuticals, Inc. | $157.63 | 4 |
| UCB, Inc. | $126.45 | 5 |
| Biogen, Inc. | $86.93 | 4 |
| Acerta Pharma LLC | $69.27 | 4 |
| SK Life Science, Inc. | $65.51 | 3 |
| Lundbeck LLC | $56.78 | 2 |
| ARGENX US, INC. | $56.14 | 3 |
| Alnylam Pharmaceuticals Inc. | $55.50 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.70 | 2 |
| Celgene Corporation | $46.00 | 2 |
| Neurelis, Inc. | $37.52 | 2 |
| EMD Serono, Inc. | $37.43 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.06 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $30.28 | 1 |
| PFIZER INC. | $27.28 | 1 |
| Genentech USA, Inc. | $24.78 | 1 |
| Octapharma USA, Inc. | $24.76 | 1 |
| MDD US Operations, LLC | $23.13 | 1 |
| Amgen Inc. | $20.37 | 1 |
| BANNER LIFE SCIENCES, LLC | $20.13 | 1 |
| Lilly USA, LLC | $19.54 | 1 |
| JAZZ PHARMACEUTICALS INC. | $18.64 | 1 |
By program year
Records — PY2024 (64)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.